Literature DB >> 11402581

Hormonal erectile dysfunction. Evaluation and management.

A Morales1, J P Heaton.   

Abstract

The clinical diagnosis of hypogonadism in the adult is difficult to establish on the basis of a history and physical examination and universally requires biochemical investigations. A serum testosterone determination is justified in men complaining of erectile dysfunction with or without alterations in sexual desire. Among the causes of erectile dysfunction, hypotestosteronemia rates are low. The prevalence of erectile dysfunction particularly is common at a period in life when alterations occur in male hormonal environment. The treatment of hypogonadal erectile dysfunction, regardless of age, is readily available, safe, and effective. The positive impact of treatment on the overall quality of life can be significant. The presence of erectile dysfunction in an aging man (> 55 years) does not imply the presence of hypogonadism, and, even if the two conditions are present, the indications for treatment require good clinical judgment. Persistent low testosterone levels may have significant detrimental effects in other organ systems; therefore, a timely diagnosis of androgen deficiency and appropriate treatment may have significant effects outside the narrow field of sexual performance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402581     DOI: 10.1016/s0094-0143(05)70138-5

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  11 in total

1.  Testosterone replacement in men with andropause: an overview.

Authors:  Michael K Brawer
Journal:  Rev Urol       Date:  2004

2.  Hormone treatments and preventive strategies in the aging male: whom and when to treat?

Authors:  Jeremy Pw Heaton
Journal:  Rev Urol       Date:  2003

3.  Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?

Authors:  Antonio Aversa; Roberto Bruzziches; Davide Francomano; Marco Natali; Andrea Lenzi
Journal:  Ther Adv Urol       Date:  2009-10

Review 4.  Erectile dysfunction and diabetes.

Authors:  Neelima V Chu; Steven V Edelman
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

Review 5.  A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?

Authors:  Konstantinos Hatzimouratidis; Dimitrios G Hatzichristou
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County Study of Urinary Symptoms and Health Status among Men.

Authors:  Naomi M Gades; Debra J Jacobson; Michaela E McGree; Jennifer L St Sauver; Michael M Lieber; Ajay Nehra; Cynthia J Girman; George G Klee; Steven J Jacobsen
Journal:  J Sex Med       Date:  2008-07-04       Impact factor: 3.802

Review 7.  Erectile dysfunction: symptom or disease?

Authors:  C Foresta; N Caretta; A Aversa; C Bettocchi; G Corona; S Mariani; M Rossato
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

8.  Total testosterone levels and the effect of sildenafil on type 2 diabetics with erectile dysfunction.

Authors:  Nabeel Najib Fadhil Hadeed; Imad Abdul-Jabar Thanoon; Samir Burhanaldin Al-Mukhtar
Journal:  Oman Med J       Date:  2014-01

Review 9.  Looking to the future for erectile dysfunction therapies.

Authors:  Konstantinos Hatzimouratidis; Dimitrios G Hatzichristou
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Sexual desire disorders.

Authors:  Keith A Montgomery
Journal:  Psychiatry (Edgmont)       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.